Boehringer Ingelheim inaugurates Ingelheim biomass plant

Pharmaceutical firm Boehringer Ingelheim inaugurated a biomass power plant at its Ingelheim site on 8 July.
With the new plant, Boehringer Ingelheim is saving around 50,000 tons of CO2 each year, with the site's own energy generation reducing by around 70%.
In total, the company is investing €205 million in sustainable infrastructure projects in Ingelheim and will be able to cover 95% of its energy requirements at the site from renewable sources in the future.
The vice chairman of the board of managing directors, Michael Schmelmer, described the commissioning as a "significant milestone" for Boehringer Ingelheim and explained: "Part of our sustainability goals is to protect natural resources so that our earth remains a place worth living in for people and animals. With an environmentally friendly and more independent energy supply, we are ensuring stable production in order to be able to deliver medications for patients worldwide."
The ceremonial inauguration was attended by the German Vice Chancellor and Federal Minister of Economics Robert Habeck and Rhineland-Palatinate Environment Minister Katrin Eder.
Habeck said: "The decarbonisation of all areas of our economy is necessary in order to achieve global climate targets on the one hand and a reduction in energy imports on the other. Boehringer Ingelheim is a good example of this. The company uses renewable energies for production. It trains and attracts talents as an attractive employer. Last but not least, it invests heavily in research and development, thus contributing to better healthcare and future proofing of the site."